Rena Buckstein

9.7k citations
194 papers · 5.2k · 2 hit papers · h-index 33

Impact in

  • Hematology top 0.2%
    • Acute Myeloid Leukemia Research
    • Hematopoietic Stem Cell Transplantation
  • Genetics top 0.5%
    • Chronic Lymphocytic Leukemia Research
    • Myeloproliferative Neoplasms: Diagnosis and Treatment

Papers in

    • Acute Myeloid Leukemia Research 87
    • Multiple Myeloma Research and Treatments 15
    • Chronic Lymphocytic Leukemia Research 31
    • Hemoglobinopathies and Related Disorders 27
    • Myeloproliferative Neoplasms: Diagnosis and Treatment 23

Rena Buckstein

184 papers receiving 5.1k citations

Rena Buckstein's Hit Papers

Multicenter, Randomized, Open-Label, Phase III Trial of Decitabine Versus Patient Choice, With Physician Advice, of Either Supportive Care or Low-Dose Cytarabine for the Treatment of Older Patients With Newly Diagnosed Acute Myeloid Leukemia 2012 · 829 citations
8290+5+11Years since publication250500750

Peers

Rena Buckstein
Comparison fields: 5 of 111
  • Hematology 2.4k
  • Genetics 1.3k
  • Pathology and Forensic Medicine 1.3k
  • Oncology 1.2k
  • Immunology 679
Replace Bernhard Wörmann with:
Bernhard Wörmann Germany
Joseph O. Moore United States
Thomas Pabst Switzerland
Dominique Bordessoule France
Vivek Roy United States
G. Verhoef Belgium
Maurice Barcos United States
Lubomir Sokol United States
Miloslav Beran United States
Sigurður Y. Kristinsson Sweden
Rena Buckstein relative to Bernhard Wörmann Germany Bernhard Wörmann's profile →
Citations per field
00.5×1.5×1.9×
Bernhard Wörmann · 1×
Citations per year

Countries citing papers authored by Rena Buckstein

Since Specialization
Citations

This map shows the geographic impact of Rena Buckstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rena Buckstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rena Buckstein more than expected).

Fields of papers citing papers by Rena Buckstein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rena Buckstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rena Buckstein. The network helps show where Rena Buckstein may publish in the future.

Co-authors

The 25 scholars most cited alongside Rena Buckstein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Rena Buckstein Line = papers co-authored together Rena Buckstein links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 194 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Multicenter, Randomized, Open-Label, Phase III Trial of Decitabine Versus Patient Choice, With Physician Advice, of Either Supportive Care or Low-Dose Cytarabine for the Treatment of Older Patients With Newly Diagnosed Acute Myeloid Leukemia
Hit paper breakdown →
2012829
2
Identification of miR-145 and miR-146a as mediators of the 5q– syndrome phenotype
Hit paper breakdown →
2009508
3 2011301
4 2009247
5 2017226
6 2017170
7 2012159
8 2003142
9 2015122
10 2019102
11 200681
12 199979
13 200476
14 201068
15 201268
16 201562
17
Stem cell function and engraftment is not affected by "in vivo purging" with rituximab for autologous stem cell treatment for patients with low-grade non-Hodgkin's lymphoma.
199961
18 200856
19 200755
20 202054

About Rena Buckstein

Rena Buckstein is a scholar working on Hematology, Genetics, Pathology and Forensic Medicine, Oncology and Molecular Biology, having authored 194 papers that have together received 5.2k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (87 papers), Lymphoma Diagnosis and Treatment (67 papers), Chronic Lymphocytic Leukemia Research (31 papers), Hemoglobinopathies and Related Disorders (27 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (23 papers), Viral-associated cancers and disorders (17 papers), Multiple Myeloma Research and Treatments (15 papers) and Neutropenia and Cancer Infections (15 papers). The work is most often cited by research in Hematology (2.4k citations), Genetics (1.3k citations), Pathology and Forensic Medicine (1.3k citations), Oncology (1.2k citations) and Immunology (679 citations). Rena Buckstein has collaborated with scholars based in Canada, United States and Italy. Frequent co-authors include Richard A. Wells, Michael J. Rauh, Hagop M. Kantarjian, Mark D. Minden, Richard A. Wells, Kevin Imrie, Brooke Snetsinger, Matthew C. Cheung, Michael Crump and David Spaner. Their work appears in journals such as Blood, Leukemia Research, Journal of Clinical Oncology, British Journal of Haematology and Annals of Hematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact